Khatri, Amit <br/><br/>
Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Apr 2016 
 - 972-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/civ1213  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Adolescent<br/>Adult<br/>Anilides--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Carbamates--administration & dosage<br/>Coinfection--drug therapy<br/>Cyclopropanes<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Drug Therapy, Combination--adverse effects<br/>Female<br/>HIV Infections--complications<br/>HIV Protease Inhibitors--administration & dosage<br/>HIV-1--drug effects<br/>Healthy Volunteers<br/>Hepacivirus--drug effects<br/>Hepatitis C--complications<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--administration & dosage<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Ritonavir--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Uracil--administration & dosage<br/>Valine<br/>Young Adult